Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma.
Worrillow LJ, Smith AG, Scott K, Andersson M, Ashcroft AJ, Dores GM, Glimelius B, Holowaty E, Jackson GH, Jones GL, Lynch CF, Morgan G, Pukkala E, Scott D, Storm HH, Taylor PR, Vyberg M, Willett E, Travis LB, Allan JM.
Worrillow LJ, et al.
J Med Genet. 2008 Mar;45(3):142-6. doi: 10.1136/jmg.2007.053850. Epub 2007 Oct 24.
J Med Genet. 2008.
PMID: 17959715
Free PMC article.